Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Automotive Industry Today.
June 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | ||||||
| 2 | 3 | 4 | 5 | 6 | 7 | 8 |
| 9 | 10 | 11 | 12 | 13 | 14 | 15 |
| 16 | 17 | 18 | 19 | 20 | 21 | 22 |
| 23 | 24 | 25 | 26 | 27 | 28 | 29 |
| 30 |
July 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | |
| 7 | 8 | 9 | 10 | 11 | 12 | 13 |
| 14 | 15 | 16 | 17 | 18 | 19 | 20 |
| 21 | 22 | 23 | 24 | 25 | 26 | 27 |
| 28 | 29 | 30 | 31 |
August 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | ||||
| 4 | 5 | 6 | 7 | 8 | 9 | 10 |
| 11 | 12 | 13 | 14 | 15 | 16 | 17 |
| 18 | 19 | 20 | 21 | 22 | 23 | 24 |
| 25 | 26 | 27 | 28 | 29 | 30 | 31 |
Press releases published on May 22, 2025
Bicara Therapeutics Announces Publication of an Abstract with Updated Interim Data from Phase 1/1b Trial of Ficerafusp alfa in 1L R/M HNSCC at the 2025 ASCO Annual Meeting
GlobeNewswire
·
May 22, 2025
BOSTON, May 22, 2025 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, today announced the publication of an …
Clear Blue Technologies International to provide Corporate Update and Report Q1 2025 Financial Results and Host Conference Call on Thursday, May 29th, 2025
GlobeNewswire
·
May 22, 2025
TORONTO, May 22, 2025 (GLOBE NEWSWIRE) -- Clear Blue Technologies International Inc. (TSXV: CBLU) the Smart Off-Grid™ Company, today announces that it will provide a corporate update and also report financial results for its first quarter 2025 on Wednesday …
Maryna Karpenko Wins Top Industry Honors for Shaping Global Communication
GlobeNewswire
·
May 22, 2025
Image courtesy of Maryna Karpenko SAN FRANCISCO, May 22, 2025 (GLOBE NEWSWIRE) -- Maryna Karpenko, a product designer at Meta, helps shape the future of global communication, earning her top industry recognition, including the MUSE Creative Award, Vega …
Onconetix, Inc. Announces Receipt of Additional Notice from Nasdaq
GlobeNewswire
·
May 22, 2025
Cincinnati, OH, May 22, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (the “Company”) announced that it received a Staff delisting letter from The Nasdaq Capital Market (“Nasdaq”) on May 20, 2025 indicating that the Company’s failure to file its …
Serina Therapeutics Appoints Stephen Brannan, M.D. to Board of Directors
GlobeNewswire
·
May 22, 2025
- Renowned neuroscience drug developer joins to support strategic development of long-acting CNS therapeutics – HUNTSVILLE, AL, May 22, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology …
From Onboarding to Settlement in Minutes: TransFi Launches BizPay to Redefine Global Business Payments
GlobeNewswire
·
May 22, 2025
TransFi launches BizPay, a unified global payment platform enabling instant, compliant cross-border transactions with AI-powered routing and 250+ local methods across 100+ countries NEW DELHI, May 22, 2025 (GLOBE NEWSWIRE) -- In a world where time zones, …
China's First Laozi Digital Human Unveiled in Sanmenxia, Henan
GlobeNewswire
·
May 22, 2025
SANMENXIA, China, May 22, 2025 (GLOBE NEWSWIRE) -- On May 20th, the ceremony of Laozi Digital Human Launch and Online Promotion, named "Dialogue Across Time and Space", took place at the Hangu Pass Historical and Cultural Tourism Zone, renowned as the " …
Guggenheim Second Quarter 2025 High Yield and Bank Loan Outlook: Credit Crossroads: Finding Value in an Era of Uncertainty
GlobeNewswire
·
May 22, 2025
NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- Guggenheim Investments, the global asset management and investment advisory business of Guggenheim Partners, today released its second quarter High Yield and Bank Loan Outlook. “Credit Crossroads: Finding Value in …
ESET participates in operation to disrupt the infrastructure of Danabot infostealer
GlobeNewswire
·
May 22, 2025
ESET Research has been tracking Danabot's activity since 2018 as part of a global effort that resulted in a major disruption of the malware's infrastructure. While primarily developed as an infostealer, Danabot also has been used to distribute additional …
ROKiT and BMW Motorrad Shaping the Future of Motorsport together
EIN Presswire
·
May 22, 2025
BMW Motorrad Motorsport and ROKiT are strengthening their partnership with a focus on nurturing young talent and expanding their international involvement LONDON, UNITED KINGDOM, May 22, 2025 /EINPresswire.com/ -- BMW Motorrad Motorsport and ROKiT …
Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Notice of General Meeting
GlobeNewswire
·
May 22, 2025
May 22, 2025 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Notice of General Meeting Biodexa Pharmaceuticals PLC, (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of …
Bio-Path Holdings to Host Corporate Update Conference Call on May 29, 2025
GlobeNewswire
·
May 22, 2025
HOUSTON, May 22, 2025 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (OTCQB:BPTH) a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer and obesity drugs, …
Made in America: Inovair High-Efficiency Blowers Are the First to Meet BABA Requirements
GlobeNewswire
·
May 22, 2025
Lenexa, Kansas , May 22, 2025 (GLOBE NEWSWIRE) -- Building on over 30 years of innovation and manufacturing excellence, Inovair has been recognized by EPA as the first and only manufacturer of high-efficiency blower packages that are fully compliant with …
All Heart Homecare Wins Best of Brooklyn 2025 for Best Home Health Aides
GlobeNewswire
·
May 22, 2025
BROOKLYN, N.Y., May 22, 2025 (GLOBE NEWSWIRE) -- All Heart Homecare Agency is proud to announce that it has been named the winner of the Best of Brooklyn 2025 Award for Best Home Health Aides. This marks the agency’s fourth win overall and its third …
Quanex Building Products Announces Second Quarter 2025 Earnings Release and Conference Call Schedule
GlobeNewswire
·
May 22, 2025
HOUSTON, TEXAS, May 22, 2025 (GLOBE NEWSWIRE) -- Quanex Building Products Corporation (NYSE: NX) (“Quanex” or the “Company”) today announced plans to release its second quarter 2025 results on Thursday, June 5, 2025, after trading closes on the New York …
VALHI ANNOUNCES QUARTERLY CASH DIVIDEND AND RESULTS OF ANNUAL STOCKHOLDER MEETING
GlobeNewswire
·
May 22, 2025
Dallas, Texas, May 22, 2025 (GLOBE NEWSWIRE) -- Valhi, Inc. (NYSE: VHI) announced today that its board of directors has declared a regular quarterly dividend of eight cents ($0.08) per share on its common stock, payable on June 26, 2025 to stockholders of …
Stifel Reports April 2025 Operating Data
GlobeNewswire
·
May 22, 2025
ST. LOUIS, May 22, 2025 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today reported selected operating results for April 30, 2025 in an effort to provide timely information to investors on certain key performance metrics. Due to the limited nature …
KMBIO announces Private sale for its P2P Exchange that connects Crypto World with Real Life
GlobeNewswire
·
May 22, 2025
GUADALAJARA, Mexico, May 22, 2025 (GLOBE NEWSWIRE) -- The countdown has begun, KMBIO an P2P exchange focusing on LATAM market has officially opened its private sale round as part of its fundraising campaign. In the midst of the global expansion of digital …
GENFIT Reports First Quarter 2025 Financial Information
GlobeNewswire
·
May 22, 2025
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), May 22, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver …
GENFIT : Information financière du premier trimestre 2025
GlobeNewswire
·
May 22, 2025
Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 22 mai 2025 – GENFIT (Nasdaq et Euronext : GNFT), société biopharmaceutique de stade clinique avancé engagée dans l’amélioration de la vie des patients atteints de maladies rares du …